In vitro diagnostics industry demand is strong in 2019 the domestic market will reach 72.3 billion

Release time:


In recent years, the in vitro diagnostic industry has developed rapidly. According to Lin Feng, Director of the Medical Equipment Registration Office of the Shanghai Food and Drug Administration, at the first Diagnostic Testing Internet of Things and Big Data Forum held on August 6, there are currently more than 7000 registrations in Shanghai. About 30% of the certificates are registration certificates related to IVD products. The development of this industry is very active and has also contributed a considerable amount of output value.
According to the data in the "China Pharmaceutical Health Blue Book (2015 Edition)" released by the China Pharmaceutical Industry Information Center, the market size of my country's in vitro diagnostic products was about 30.6 billion billion yuan in 2014, and the market size is expected to reach 72.3 billion billion yuan in 2019.
In foreign countries, in vitro diagnostics are also hot. According to a report released by Allied Market Research (AMR), the global in vitro diagnostics market was worth US $53.3 billion in 2013, will grow at a compound annual growth rate (CAGR) of 5.34 per cent in the next few years, and will reach US $74.7 billion in 2020.
"China's IVD accounts for less than 15% of the global share, showing a small base and high growth rate. This is why many international companies have begun to seize the Chinese market." Li ji, deputy general manager of Shanghai kehua biological engineering co., ltd., said that at present, the global IVD concentration is very high, forming a 4 + X pattern. the first echelon is Roche, Siemens, Abbott and Danaher (acquiring Beckman), while x includes Syme Fly, BD, meilier and sysenmeikang. in 2012, the world's top 10 IVD enterprises accounted for more than 80% of the global market share, and the domestic market was basically occupied by brand imports, "At present, there are only about 10 domestic production enterprises with an annual output value of more than 0.5 billion yuan. For Chinese diagnostic enterprises, there is a long way to go."
It is reported that there have been some IVD representative enterprises with good development in China, including Kehua Biology, Da 'an Gene, Lidman, Dirui Medical, Jiuqiang Biology, Meikang Biology, Mike Biology, Wanfu Biology, etc.
How will in vitro diagnostics evolve in the future?
The industry believes that the main points include the following:
One is the rapid expansion of types and the acceleration of updated applications.
Second, the sensitivity is higher and the specificity is stronger.
Third, multi-species integrated testing for certain diseases will begin to appear.
The fourth is the detection method of non-destructive sampling. The last point is OTC diagnosis.
From a technical point of view, it can be summarized in four points:
Highly integrated, automated, fully automated system
Simple and fast diagnosis is more popular.
Single instrument, multi-platform detection
Single project multi-platform application
Three major factors to promote China's in vitro diagnostic industry demand is strong 1, with the advancement of medical reform, health investment is increasing, resulting in the release of medical demand, per capita treatment costs rise, also boosted the demand for in vitro diagnostic reagents.
2. The proportion of the elderly population is constantly increasing. By 2020, the overall aging level is expected to reach 17.17 per cent, which shows that the demand for testing will increase in the future. At the same time, the incidence of chronic diseases/infectious diseases will remain high, bringing about a steady increase of 5-8% in the number of visits.
3. With the improvement of residents' disposable income, people's awareness of disease prevention is constantly increasing. People no longer seek medical treatment for illness, but will pay more attention to health management issues. Everyone's awareness of physical examination is also increasing. According to relevant data, the growth rate of the entire physical examination market has reached 20%-30% since 2005.